ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

EDIT Editas Medicine Inc

5,54
0,33 (6,33%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Editas Medicine Inc EDIT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,33 6,33% 5,54 01:56:42
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,21 5,21 5,67 5,47 5,21
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202414:00GLOBEEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T..
22.4.202422:31GLOBEEditas Medicine to Present Pre-clinical Data Demonstrating..
06.3.202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:58EDGAR2Form 144 - Report of proposed sale of securities
28.2.202423:13EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28.2.202422:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
28.2.202413:06EDGAR2Form 8-K - Current report
28.2.202413:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
21.2.202413:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
14.2.202414:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.1.202415:00GLOBEEditas Medicine to Participate in Upcoming Investor..
08.1.202414:15GLOBEEditas Medicine Highlights 2024 Anticipated Milestones and..
03.1.202413:00GLOBEEditas Medicine to Present at the 42nd Annual J.P. Morgan..
13.12.202318:48DJNEditas Medicine Strikes License Deal With Vertex..
13.12.202315:49DJNEditas Medicine Strikes License Deal With Vertex..
13.12.202315:02EDGAR2Form 8-K - Current report
13.12.202315:00GLOBEEditas Medicine and Vertex Pharmaceuticals Enter into..
11.12.202322:23EDGAR2Form 8-K - Current report
11.12.202318:00GLOBEEditas Medicine Announces New EDIT-301 Safety and Efficacy..
07.12.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202322:10EDGAR2Form 8-K - Current report
16.11.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202321:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202312:06EDGAR2Form 8-K - Current report
03.11.202312:00GLOBEEditas Medicine Announces Third Quarter 2023 Results and..
02.11.202314:12GLOBEEditas Medicine to Present Clinical Data from the RUBY and..
27.10.202313:00GLOBEEditas Medicine Announces Third Quarter 2023 Results..
16.10.202314:00GLOBEEditas Medicine Granted FDA Regenerative Medicine Advanced..
10.10.202322:05EDGAR2Form 8-K - Current report
25.9.202322:30GLOBEEditas Medicine Reports Inducement Grants to New Chief..
25.9.202315:00GLOBEEditas Medicine Strengthens Executive Leadership Team with..
07.9.202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.8.202315:00GLOBEEditas Medicine Announces Upcoming Investor Events
28.8.202313:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
15.8.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.8.202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.8.202313:16EDGAR2Form 8-K - Current report
02.8.202313:00GLOBEEditas Medicine Announces Second Quarter 2023 Results and..
27.7.202315:00GLOBEEditas Medicine and Azzur Group Expand Partnership to..
26.7.202313:00GLOBEEditas Medicine Announces Second Quarter 2023 Results..
25.7.202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.7.202322:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
25.7.202314:00GLOBEEditas Medicine Reports Inducement Grant to New Chief..
24.7.202313:00GLOBEEditas Medicine Strengthens Executive Leadership Team with..
21.7.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock